DUBLIN, March 22, 2023 /PRNewswire/ — “Diabetes Diagnostics: Global Strategic Business Report” has been added to the by ResearchAndMarkets.com offering.
Global Diabetes Diagnostics Market to Reach $59.4 Billion in 2030
The global market for Diabetes Diagnostics is estimated at US$30.8 Billion in the year 2022, it is expected to reach a modified size of US$59.4 Billion in 2030, growing at a CAGR of 8.6% during the analysis period 2022-2030.
Test Strips, one of the segments analyzed in the report, is expected to record an 8.7% CAGR and reach. US$14.7 Billion at the end of the analysis period. Considering the ongoing post pandemic recovery, the growth of the Lancets segment is revised to a revised 7.9% CAGR for the next 8-year period.
The US Market is estimated at $11.7 BillionMeanwhile China is Predicted to Grow at 10.1% CAGR
The Diabetes Diagnostics market in the US is estimated at US$11.7 Billion in the year 2022. Chinathe second largest economy in the world, is estimated to reach the projected market size of US$7.6 Billion by the year 2030 following a CAGR of 10.1% during the analysis period 2022 to 2030.
Among other important geographic markets are Japan and Canada, each forecast to grow by 6.9% and 7.6% respectively in the 2022-2030 period. CONTENTS Europe, Germany’s is estimated to grow at approximately 8.6% CAGR. Led by countries like australian, Indiaand South Koreathe market of Asia-Pacific predicted to arrive US$6.7 Billion in the year 2030.
Looking forward to 2023
The world economy is at a critical crossroads with many interconnected challenges and crises running parallel.
A drop in capital spending is imminent as companies slow investment, held back by concerns about inflation and weak demand. With slow growth and high inflation, developed markets seem poised to enter a recession. Fear of new COVID outbreaks and in China The uncertain post-pandemic path poses a real risk that the world will experience more severe supply chain pain and manufacturing disruptions this year.
The year 2023 is expected to be a difficult year for most markets, investors and consumers. However, there is always an opportunity for businesses and their leaders to be able to plan a path forward with resilience and adaptability.
What’s New for 2023?
Special coverage of Russia–Ukraine war; global inflation; easing the zero-Covid policy of China and its ‘bumpy’ opening; supply chain disruptions, global trade tensions; and recession risk.
Global competition and the main percentage of competitive market share
Market presence in multiple geographies – Strong / Active / Niche / Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archive and Research Platform
Complimentary updates for one year
Main Topics:
END OF THE MARKET
Influencer Market Insights
World Market Trajectories
Impact of COVID-19 and a Looming Global Recession
Technologies Help for Diagnosis, Monitoring and Management of Diabetes
Diabetes: A Chronic Disease
An Introduction to Diabetes Diagnostics
Diabetes Diagnostics: Easier, Economical, and Efficient Management of the Global Diabetes Epidemic
Developed Regions Lead, Developing Economies to Lead Future Growth
Growth in the Number of Hospitals and Diagnostics Centers is Proving Good for the Market in Developing Regions
Alarming Rate of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
Diabetes Emerges as One of the Leading Causes of Mortality
Competition
Quality Products at Low Prices: Mantra for Marketing Success
SMBG Creators Turn to Mobile Devices to Get Users to Switch
Global brands
New Market Activity
Competitive Market Presence – Strong / Active / Niche / Trivial for Global Players in 2022 (E)
TRENDS AND DRIVERS
High Risk of Diabetes in Rapidly Expanding Aging Population Benefit Market Expand
Rising Healthcare Spending Aids Diabetes Diagnostics & Testing Market
Rising Obesity Levels Drive Market Growth
Average Per Capita Annual Health Expenditure (In US$) due to Obesity
The Rising Importance of Real-Time Glucose Sensing and Monitoring Driving Steady Growth in the Minimally-Invasive CGM Devices Market
CGM Demand Benefits from the COVID-19 Pandemic
The CGM market has broken barriers to witness growing adoption
Growing Role of HbA1c Testing Devices in Diabetes Monitoring and Management
Increasing Popularity of Near-Patient Testing Benefits the HbA1c Devices Market
Multiple Benefits of POC HbA1c Lab Test Drive Widespread Adoption
Glycated Albumin: A Potential Threat to HbA1c
Role of HbA1c Testing in the Diagnosis and Management of Diabetes
HbA1c Tests for Diabetes Diagnosis Should Solve Issues Related to Hemoglobin Variants
Glycosylated Hemoglobin Tests Lead the Way for Early Diabetes Diagnosis
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continue to Witness Growth in Demand
Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
Blood Sugar Lancets Market: Continued Growth in Demand
Self/Home Blood Glucose Monitoring Continues Market Growth
Rising Smartphone Penetration Augurs Good for SMBG Market
Smartphone Penetration Rate as a Share of the Total Population: 2016-2020
Barriers to the Adoption of New Technologies in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Insulin Pens Increase Popularity of Insulin Administration
Smart Insulin Pens
Increasing Role of Self-Injection Devices in Diabetes Management
Prefilled Syringe Pen Injector
Human Factors Influence the Design of Self Injection Systems
Pain Free Shots: A Growing R&D Domain
Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translating Untapped Potential for Diabetes Diagnostics Market
Increasing Vulnerability of Diabetics to Various Health Complications Increases Demand for Diagnostic Devices
Product Innovations and Improvements: Key Focus Areas for Vendors
Focus on Development of Wearable Devices
An Insight into the Exciting Advances in Blood Glucose Monitoring Methods
Companies Develop New Needle-Free Alternatives
mHealth Solutions for Diabetes Diagnosis
Non-invasive Wearable Glucose Testing Devices
Innovations in Insulin Pumps
FOCUS ON SELECT PLAYERS (Total 91 Featured)
A.Menarini Diagnostics Ltd.
Abbott Diabetes Care, Inc.
Acon Laboratories, Inc.
AgaMatrix, Inc.
Apex Biotechnology Corporation
ARKRAY, Inc.
Ascensia Diabetes Care Holdings AG
B.Braun Melsungen AG
Becton, Dickinson and Company
BIONIME Corporation
Bio-Rad Laboratories, Inc.
Danaher Corporation
Beckman CoulterInc.
HemoCue AB
DexCom, Inc.
Diazyme Laboratories Inc.
EKF Diagnostics Holdings Plc
LifeScan, Inc.
Medtronic PLC
Nova Biomedical Corporation
OSANG Healthcare Co., Ltd.
Roche Diabetes Care, Inc.
Sanofi SA
Sanwa Kagaku Kenkyusho Co., Ltd.
Siemens Healthineers
Sinocare, Inc.
PTS Diagnostics
Trividia Health, Inc.
TaiDoc Technology Corporation
Tandem Diabetes Care, Inc.
Terumo Corporation
Tosoh Bioscience, Inc.
Trinity Biotech plc
Ypsomed AG
For more information about this report visit https://www.researchandmarkets.com/r/8leahi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura WoodSenior Manager
press@researchandmarkets.com
For EST Office Hours Call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-diabetes-diagnostics-business-report-2023-2030-quality-products-at-low-prices—the- mantra-for-success-in-the-marketplace-301778511.html
SOURCE Research and Markets
